Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences (NBIX) sees a surge in social engagement and mentions, driven by strong Ingrezza sales and positive study results. However, the company faces headwinds from missed EPS estimates and a failed clinical trial.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Neurocrine Biosciences, Inc. (NBIX) trading volume is up 136.47% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) social dominance is up 119.52% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) creators is up 62.16% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) engagements is up 2781.45% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) mentions is up 103.68% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) posts created is up 535.29% from the previous week.
- Neurocrine Biosciences, Inc. entered the top [--] AltRank™ for the first time
Price: $137
Price 24-Hour Time-Series Raw Data
The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment.
24-Hour: 2.09% 7-Day: -0.51% 30-Day: 1.79%
1-Year High: $155.60 on 2025-12-10
1-Year Low: $87.50 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #1,587 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] [----]
[--] Month: [-----] +791
[--] Months: [-----] +676
[--] Year: [-----] +786
1-Year High: [-----] on 2026-02-01
1-Year Low: [--] on 2025-07-12
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-02
1-Year Low: [--] on 2025-09-24
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-------] +2,781%
[--] Month: [-------] +110%
[--] Months: [---------] -57%
[--] Year: [---------] -2.90%
1-Year High: [-------] on 2025-05-05
1-Year Low: [---] on 2026-02-01
Engagements by network (24h): Reddit: [--] News: [--] X: [-----] YouTube: [--] TikTok: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +104%
[--] Month: [---] +17%
[--] Months: [-----] -86%
[--] Year: [------] +258%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): Reddit: [--] News: [--] X: [--] YouTube: [--] TikTok: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is up 24% from [--] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +62%
[--] Month: [---] -10%
[--] Months: [---] -93%
[--] Year: [------] +700%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @OracleEarnings | [--] | [------] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [--] |
| @doepke_michel | [--] | [-----] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @d__risk | [--] | [-----] | [--] | [--] |
| @AIStockSavvy | [--] | [------] | [--] | [--] |
| @WealthBranch | [--] | [-----] | [--] | [--] |
| @neurocrinebiosciencesinc | [--] | [--] | [--] | [--] |
Sentiment: 73%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 73%
Daily Average: 67%
[--] Week: 100% no change
[--] Month: 50% -33%
[--] Months: 50% -25%
[--] Year: 50% +2%
1-Year High: 100% on 2025-07-20
1-Year Low: 25% on 2025-09-15
Most Supportive Themes:
- Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
- Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline.
- Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
Most Critical Themes:
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
Social Dominance: 0.00477%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00477%
Daily Average: 0.02%
[--] Week: 0.00461% +0.00251%
[--] Month: 0.0087% +0.0013%
[--] Months: 0.0087% -0.0052%
[--] Year: 0.0087% -0.023%
1-Year High: 0.211% on 2025-07-03
1-Year Low: 0.0021% on 2025-12-07
Market Dominance: 0.014%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.014%
Daily Average: 0%
1-Year High: 0.654% on 2026-02-06
1-Year Low: 0.014% on 2026-02-18
Market Cap: $12,822,436,033
Market Cap 24-Hour Time-Series Raw Data
Current Value: $12,822,436,033
Daily Average: $13,022,272,648
[--] Week: $12,822,436,033 -6.60%
[--] Month: $12,822,436,033 -2.90%
[--] Months: $12,822,436,033 -4.40%
[--] Year: $12,822,436,033 +12%
1-Year High: $15,517,197,780 on 2025-12-10
1-Year Low: $8,990,517,324 on 2025-04-12
Top Neurocrine Biosciences, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"
X Link @undefined 2025-12-31T18:48Z [----] followers, 17.9K engagements
"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK"
X Link @Andre_AGTC 2025-09-30T14:34Z [----] followers, 37K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing